Growth Metrics

Nu-Med Plus (NUMD) Net Cash Flow Growth (1y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Nu-Med Plus - - - 22.84%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 22.84%
Dec 31, 2024 61.05%
Jun 30, 2024 89.97%
Mar 31, 2024 97.77%
Dec 31, 2023 82.47%
Sep 30, 2023 -3,104.62%
Jun 30, 2023 -809.42%
Mar 31, 2023 -120.68%
Dec 31, 2022 -21.17%
Sep 30, 2022 101.53%
Jun 30, 2022 96.18%
Mar 31, 2022 81.44%
Dec 31, 2021 -112.84%
Sep 30, 2021 -261.43%
Jun 30, 2021 -443.56%
Mar 31, 2021 -537.74%
Dec 31, 2020 551.70%
Sep 30, 2020 -2.91%
Jun 30, 2020 -61.03%
Mar 31, 2020 107.80%
Dec 31, 2019 -4,540.72%
Sep 30, 2019 121.77%
Jun 30, 2019 -158.48%
Mar 31, 2019 -90.73%
Dec 31, 2018 98.71%
Sep 30, 2018 -182.41%
Jun 30, 2018 124.03%
Mar 31, 2018 -124.79%
Dec 31, 2017 -626.52%
Sep 30, 2017 499.95%
Jun 30, 2017 -8.43%
Mar 31, 2017 437.74%
Dec 31, 2016 -63.94%
Sep 30, 2016 -247.22%
Jun 30, 2016 -2,091.33%
Mar 31, 2016 231.06%
Dec 31, 2015 181.16%
Sep 30, 2015 -119.18%
Jun 30, 2015 -107.19%
Mar 31, 2015 -690.11%
Dec 31, 2014 -157.91%
Sep 30, 2014 62,076.14%
Jun 30, 2014 597.27%
Mar 31, 2014 -283.55%
Dec 31, 2013 169.53%
Sep 30, 2013 100.52%
Jun 30, 2013 110.80%
Mar 31, 2013 -94.86%